panCELLa welcomed Cartherics as a capable partner in the addressing of needs of cancer patients treated with immunotherapy. Cartherics Pty Ltd, the pluripotent stem cell technology developing Australian company and the Canada based panCELLa Inc, an early-stage biotechnology company, recently announced that they will be collaborating on the research and …
The safety profile of DARZALEX was unchanged in case of a split or single initial dose and there were no safety events in case of the split-dosage regimen. The Janssen Pharmaceutica recently announced that it has received approval from the U.S. Food and Drug Administration for split-dosage regimen of DARZALEX®(daratumumab). …
The deal is to be renewed every two years after its initial five-year term and will continue thus until cancelled. WuXi Biologics, a leader in biologics discovery, development and manufacturing offering open-access biologics technology recently announced that it has entered into an exclusive manufacturing partnership with Amicus Therapeutics, a biotechnology …
The agreement showcases the interest of prominent orthobiologic firms in Kuros technologies. The global partner would be responsible for marketing an advanced bone graft that would be supplied by Kuros. Kuros Biosciences (Kuros), a renowned Swiss biotechnology company, has reportedly announced that the company’s Dutch subsidiary has entered into an Original …
Precision for Medicine has announced the acquisition of ApoCell, a Houston-based next-generation lab that specializes in the identification and analysis of biomarkers. By acquiring ApoCell, its ApoStream® liquid biopsy technology and extensive tissue profiling expertise will be added to Precision’s strong portfolio of specialty laboratory and biomarker informatics services. The …
SQZ Biotechnologies, a cell therapy conglomerate renowned for developing novel treatments for a wide range of diseases, has recently announced the expansion of its collaboration with Roche in cellular therapy. As per trusted sources, the expanded partnership with Roche’s cancer immunotherapy expertise would further SQZ’s innovation synergistic combination as well …
The Basel headquartered healthcare company Roche Holding AG has globally launched three next-generation sequencing AVENIO Tumor Tissue Analysis Kits for use in oncology research. The new AVENIO Tumor Tissue Targeted Kit, Surveillance Kit and Expanded Kit help to detect all four mutation classes in solid tumors and compliment Roche’s NGS …
The U.S. based pharmaceutical firm Eli Lilly and Company has reportedly announced to have forayed in the autoimmune segment in India. As per trusted sources, the drug maker has launched a new once-daily oral therapy, named as Olumiant, to treat rheumatoid arthritis. Reportedly, OlumiantTM is an advanced and effective once-daily …
Bristol-Myers Squibb (BMS) and Compugen, the Israeli genomics-based drug and diagnostic discovery company have made an announcement recently informing that the two companies have entered into a clinical trial partnership. The companies will undertake trial to evaluate COM701 from Compugen with Opdivo, BMS’s PD-1 immune checkpoint inhibitor, in patients having …
Los Angeles-based cannabis firm, MedMen Enterprises Inc. has recently announced its binding letter of intent to acquire the Illinois-based medical cannabis provider PharmaCann LLC for a valuation of USD 682 million. With thus takeover, MedMen will be expanding its reach with 79 licensed cannabis facilities amid growing operations in 12 …